BCIQ Profiles

Company Profile Report
0322 EpimAb
BioCentury & Getty Images

Finance

Crossovers invest ahead of pre-IPO round, as bispecifics play EpimAb readies to deploy $120M series C

Mirae, Cormorant, Octagon among investors in Shanghai company’s latest venture round

Mirae, Cormorant, Octagon among investors in Shanghai company’s latest venture round.

Mar 23, 2021 | 1:16 AM GMT

After raising a $120 million series C round co-led by China Merchants Bank International and Mirae Asset Financial Group, EpimAb now turns to executing on its trio of clinical

Read the full 767 word article

How to gain access

Continue reading with a
two-week free trial.